Full Text
PSY184 - HTA AND REIMBURSEMENT CONSIDERATIONS FOR RARE DISEASES IN EUROPEAN MARKETS- WHAT ARE THE IMPLICATIONS FOR MANUFACTURERS?S?

Abstract

Authors

A.E. Heyes D. McBride I. Pearson C. Copley-Merriman

Back to Volume 21, Supplemental S3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×